EDGAR Filing Documents for 0001493152-23-027193

Form 8-K - Current report:

SEC Accession No. 0001493152-23-027193

Filing Date

2023-08-08

Accepted

2023-08-08 17:06:10

Documents

Period of Report

2023-08-04

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	57915
2		ex1-1.htm	EX-1.1	115589
3		ex4-1.htm	EX-4.1	139787
4		ex4-2.htm	EX-4.2	118063
5		ex4-3.htm	EX-4.3	165216
6		ex10-1.htm	EX-10.1	264127
7		ex99-1.htm	EX-99.1	11354
8		ex99-2.htm	EX-99.2	10609
	Complete submission text file	0001493152-23-027193.txt		1235425

Data Files

Seq	Description	Document	Type	Size
9	XBRL SCHEMA FILE	invo-20230804.xsd	EX-101.SCH	3033
10	XBRL LABEL FILE	invo-20230804_lab.xml	EX-101.LAB	34240
11	XBRL PRESENTATION FILE	invo-20230804_pre.xml	EX-101.PRE	22371
13	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3207

Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240

Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505

INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)